Polymer-Encapsulated PC12 Cells: Long-Term Survival and Associated Reduction in Lesion-Induced Rotational Behavior

Intrastriatal implantation of a dopaminergic cell line surrounded by a permeable, thermoplastic membrane was investigated as a method of long-term dopamine (DA) delivery within the central nervous system (CNS). An increase in DA release from PC12 cell-loaded capsules maintained in vitro was associated with an increase in mitotic activity of the encapsulated cell line. A significant reduction in apomorphine-induced rotational behavior was observed after PC12 cell-containing capsules were implanted into unilaterally 6-hydroxydopamine (6-OHDA) lesioned rats, which was sustained for 24 wk. Four wk after implantation, micro-dialysis studies revealed the presence of DA near PC12 cell-containing capsules, which was comparable to extracellular striatal levels of unlesioned controls. Extracellular striatal DA was undetectable by microdialysis in lesioned animals near empty polymer capsules. Histological analysis after 24 wk in vivo demonstrated that encapsulated PC12 cells survived, continued to express tyrosine hydroxylase, and that encapsulation prevented tumorigenesis. The data suggested that the release of a diffusible substance, most likely DA, from an implant is sufficient to exert a long-term functional influence upon 6-OHDA unilaterally lesioned rats and that capsules containing DA-secreting cells may be an effective method of long-term DA delivery in the CNS.

[1]  W. Freed,et al.  Transplanted adrenal chromaffin cells in rat brain reduce lesion-induced rotational behaviour , 1981, Nature.

[2]  A. Björklund,et al.  Reinnervation of the denervated striatum by substantia nigra transplants: Functional consequences as revealed by pharmacological and sensorimotor testing , 1980, Brain Research.

[3]  A. Björklund,et al.  Mechanisms of action of intracerebral neural implants: studies on nigral and striatal grafts to the lesioned striatum , 1987, Trends in Neurosciences.

[4]  S Shimohama,et al.  Grafting fibroblasts genetically modified to produce L-dopa in a rat model of Parkinson disease. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[5]  U. Ungerstedt,et al.  Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system. , 1971, Acta physiologica Scandinavica. Supplementum.

[6]  J. Mallet,et al.  Behavioural Effect of Engineered Cells that Synthesize L‐DOPA or Dopamine after Grafting into the Rat Neostriatum , 1990, The European journal of neuroscience.

[7]  Shelley R. Winn,et al.  Transplantation of neural tissue in polymer capsules , 1988, Brain Research.

[8]  A. Bjo¨rklund,et al.  Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants , 1979, Brain Research.

[9]  P Aebischer,et al.  Brain tissue reaction to permselective polymer capsules. , 1989, Journal of biomedical materials research.

[10]  J. Marshall.  Somatosensory inattention after dopamine-depleting intracerebral 6-OHDA injections: Spontaneous recovery and pharmacological control , 1979, Brain Research.

[11]  A. Björklund,et al.  In vivo release of DOPA and dopamine from genetically engineered cells grafted to the denervated rat striatum , 1990, Neuron.

[12]  L. Greene,et al.  Release, storage and uptake of catecholamines by a clonal cell line of nerve growth factor (NGF) responsive pheochromocytoma cells , 1977, Brain Research.

[13]  B J Hoffer,et al.  Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system. , 1979, Science.

[14]  Shelley R. Winn,et al.  Long-term cross-species brain transplantation of a polymer-encapsulated dopamine-secreting cell line , 1991, Experimental Neurology.

[15]  T. Robinson,et al.  Involvement of nigrostriatal dopamine neurons in the contraversive rotational behavior evoked by electrical stimulation of the lateral hypothalamus , 1985, Brain Research.

[16]  Ian Q. Whishaw,et al.  Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats , 1988, Brain Research.

[17]  Shelley R. Winn,et al.  Behavioral recovery following intrastriatal implantation of microencapsulated PC12 cells , 1991, Experimental Neurology.

[18]  P Aebischer,et al.  Macroencapsulation of dopamine-secreting cells by coextrusion with an organic polymer solution. , 1991, Biomaterials.

[19]  F. Hefti,et al.  Implantation of PC12 cells into the corpus striatum of rats with lesions of the dopaminergic nigrostriatal neurons , 1985, Brain Research.

[20]  L. Greene,et al.  Differential cytotoxic activities of antisera against nerve growth factor-treated and untreated clonal pheochromocytoma cells , 1980, Neuroscience.

[21]  P. Tresco,et al.  An encapsulated dopamine-releasing polymer alleviates experimental parkinsonism in rats , 1989, Experimental Neurology.

[22]  C. Pycock.  Turning behaviour in animals , 1980, Neuroscience.

[23]  L. Greene,et al.  Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[24]  K. Jellinger,et al.  Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. , 1973, Journal of the neurological sciences.

[25]  F. Gage,et al.  In vivo measurement of spontaneous release and metabolism of dopamine from intrastriatal nigral grafts using intracerebral dialysis , 1986, Brain Research.